A Study for Patients With Diabetes Mellitus (IOPA)

• Status: Completed
• Trial end date: 2008-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare glycemic control (HbA1c) in Chinese patients with type 1 or type 2 diabetes when treated with insulin lispro low mixture and human insulin 30/70.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Insulin; Insulin Lispro; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Clinically diagnosed type 1or type 2 diabetes for at least 2 months

• Aged between 18 and 70 (inclusive)

• Have been treated with human insulin mix 30/70 twice daily for at least 2 months prior to entering the study

• Have glycosylated hemoglobin (Hb1Ac) between 1.2 and 1.7 times the upper limit of normal reference range within 2 weeks prior to or at Visit 1

• Compliance with diet and insulin therapy and performs regular blood glucose monitoring

Exclusion Criteria:

• Have used oral antidiabetic agents within 30 days prior to entry into the study

• Receive a total daily dose of insulin >2 units/kilogram

• Have had more than two episodes of severe hypoglycemia within 6 months prior to entry into the study

• Have a body mass index >35 kilograms per square meter (kg/m2)

• Receive chronic systemic glucocorticoid therapy